Home › NDC Lookup › Ingredients › Calcium Carbonate And Magnesium Hydroxid... › 41167-1003-05
Rolaids Ultra Strength Mint Calcium carbonate and Magnesium hydroxide 1000 mg; 200 mg Tablet, Chewable — NDC 41167-1003-05 package photo

Rolaids Ultra Strength Mint Calcium carbonate and Magnesium hydroxide 1000 mg; 200 mg Tablet, Chewable

by Chattem, Inc. · 3 PACKAGE in 1 CELLO PACK (41167-1003-5) / 10 TABLET, CHEWABLE in 1 PACKAGE (41167-1003-4)
NDC 41167-1003-05
🏷️ FDA NDC (as labeled) 41167-1003-5 billing pads the package segment with a zero
This package
Contains10 tablet, chewable in 1 package Pack sizes5 compare ↓
Also comes in: 10 tablets 41167-1003-04 72 tablets 41167-1003-01 87 tablets 41167-1003-02 160 tablets 41167-1003-03
OTC Discontinued Non-controlled ⚠ Discontinued by firm
🗂️ Data synced Sep 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

🆔 Identity & classification

FDA NDC (as labeled) 41167-1003-5
Product NDC 41167-1003
11-digit billing NDC 41167100305
RxCUI 1438105, 1438107
UNII H0G9379FGK, NBZ3QY004S
UPC 0041167100318
Application # M001
SPL Set ID 8806c912-ab83-4f45-ac78-e826bb3143d4
Established class (EPC) Blood Coagulation Factor; Calculi Dissolution Agent; Cations; Inhi
Physiologic effect Increased Coagulation Factor Activity; Increased Large Intestinal Motility; Inhibition Large Intestine Fluid/Electrolyte Absorption
Chemical class Calcium; Divalent
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm
Marketing start 2013-09-01
Route ORAL
Dosage form TABLET, CHEWABLE
Substance CALCIUM CARBONATE; MAGNESIUM HYDROXIDE
Why two NDCs? The FDA registers this code as 41167-1003-5 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 41167-1003-05. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Calcium compounds class.

Drug family (ATC) Calcium compounds, Calcium
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerChattem, Inc.
FDA applicationM001 (OTC MONOGRAPH DRUG)
Labeler code41167
First marketedSep 2013
Product typeHuman Otc Drug
Portfolio157 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

Rolaids Ultra Strength Mint is a chewable tablet taken by mouth that contains calcium carbonate and magnesium hydroxide. These two ingredients are commonly used together in antacid products to help neutralize stomach acid and provide relief from heartburn and indigestion. This product is an over-the-counter antacid marketed under FDA's standard rules for antacid drugs rather than as an individually approved medication.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color white
ShapeRound
ImprintR;U
Size19 mm
ScoringNot scored
FlavorMint
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 96K6UQ3ZD4
    Sucralose is a synthetic sweetener made from sugar. It's added to medicines to improve taste without adding calories, helping make bitter or unpleasant-tasting drugs easier to take.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesdextrose, flavor, magnesium stearate, silicon dioxide, stearic acid, sucralose, sucrose (309-055) As a daily source of calcium and magnesium, chew 2 tablets twice daily. Supplement Facts Serving Size: 2 Tablets, Servings Per Container: 36, Amount Per Serving: Calories 12, Total Carb 2 g (<1% DV*), Sugars 2 g (†DV), Calcium 800 mg (54% DV), Magnesium 170 mg (29% DV). *Percent Daily Values (DV) are based on a 2,000 calories diet. †Daily Value not established.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 10 tablets 72 tablets 87 tablets 160 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Rolaids Ultra Strength Mint 1000 mg/1; 200 mgthis 41167-1003-05 Chattem, 10 tablets — — Discontinued —
Rolaids Ultra Strength Antacid Assorted Fruit 1000 mg/1; 200 mg 69423-0825-10 THE 10 tablets — — FDA listed —
Rolaids Ultra Strength Mint 1000 mg/1; 200 mg 69423-0828-10 THE 10 tablets — — FDA listed —
Rolaids Ultra Strength 1200 1000 mg/1; 200 mg 84126-0322-10 THE 10 tablets — — FDA listed —
Rolaids ULTRA STRENGTH 1200 1000 mg/1; 200 mg 84126-0325-10 THE 10 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2013
On the market since
Sep 2013
📍
2026
Currently FDA-listed
13 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Rolaids Ultra Strength Mint (this brand).

Top reported reactions

Chronic Kidney Disease2
Renal Failure2
Acute Kidney Injury1
End Stage Renal Disease1
Nephrogenic Anaemia1
Product Odour Abnormal1
Product Taste Abnormal1

Age at onset

Adult1

Reporter sex

4 reports
Female · 100%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
41167-1003-01 72 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (41167-1003-1) 2013-09-01 Active
41167-1003-02 87 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (41167-1003-2) 2013-09-01 Discontinued by firm
41167-1003-03 160 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (41167-1003-3) 2013-09-01 Discontinued by firm
41167-1003-05 You're viewing this 3 PACKAGE in 1 CELLO PACK (41167-1003-5) / 10 TABLET, CHEWABLE in 1 PACKAGE (41167-1003-4) 2013-09-01 Discontinued by firm
41167-1003-04 10 TABLET, CHEWABLE in 1 PACKAGE (41167-1003-4) 2013-09-01 Active

Pack size FAQ

What quantity is in NDC 41167-1003-05?
NDC 41167-1003-05 is listed by the FDA — 3 package in 1 cello pack / 10 tablet, chewable in 1 package.
What NDC number is used to bill for this package of Rolaids Ultra Strength Mint Calcium carbonate and Magnesium hydroxide 1000 mg; 200 mg Tablet, Chewable?
Bill NDC 41167-1003-05 — the 11-digit billing format is 41167100305. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 41167-1003-5, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 41167-1003-05, written without dashes as 41167100305. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 41167-1003-05, the first segment (41167) is the labeler code FDA assigned to Chattem, Inc.; the middle segment (1003) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (05) identifies this exact package size and type. Together they name one specific package of one specific product.
Does this product come in other package sizes?
Yes — the FDA directory lists 4 other package presentations of this same product, including 10 tablets (41167-1003-04), 72 tablets (41167-1003-01), 87 tablets (41167-1003-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Chattem, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 7 words ▾

Use relieves: heartburn sour stomach acid indigestion

⏱️ Dosage and Administration 13 words ▾

Directions chew 2-3 tablets as symptoms occur, or as directed by a doctor

⚠️ Warnings 55 words ▾

Warnings Ask a doctor or pharmacist before use if you are now taking a prescription drug. Antacids may interact with certain prescription drugs. When using this product do not take more than 7 tablets in a 24-hour period do not use the maximum dosage for more than 2 weeks Keep out of reach of children.

🧪 Active Ingredient 15 words ▾

Active ingredient (in each tablet) Calcium carbonate USP 1000 mg Magnesium hydroxide USP 200 mg

🧪 Inactive Ingredients 76 words ▾

Inactive ingredients dextrose, flavor, magnesium stearate, silicon dioxide, stearic acid, sucralose, sucrose (309-055) As a daily source of calcium and magnesium, chew 2 tablets twice daily. Supplement Facts Serving Size: 2 Tablets, Servings Per Container: 36, Amount Per Serving: Calories 12, Total Carb 2 g (<1% DV*), Sugars 2 g (†DV), Calcium 800 mg (54% DV), Magnesium 170 mg (29% DV). *Percent Daily Values (DV) are based on a 2,000 calories diet. †Daily Value not established.

🎯 Purpose 2 words ▾

Purpose Antacid

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 41167-1002-00 · Chattem, 41167-1031-02 · Chattem, →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.